Document Detail


A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease.
MedLine Citation:
PMID:  17027569     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Current lipid guidelines recommend that therapy be targeted primarily at low-density lipoprotein (LDL) cholesterol, and that other lipid indexes may be used as secondary or supplementary targets. Emerging data have suggested that measures such as non-high-density lipoprotein (HDL) cholesterol, apolipoprotein-B, or the total/HDL cholesterol ratio may be more predictive of cardiovascular risk than LDL cholesterol. We conducted a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey to directly compare the strengths of the associations among various lipid-related indexes and clinical features consistent with atherosclerotic disease. From approximately 9,500 data sets in the overall analysis, the apolipoprotein-B/HDL cholesterol ratio emerged as the strongest correlate (odds ratio 1.177 per 1 mg/dl increment, 95% confidence interval 1.063 to 1.302, p <0.01), followed by the total or non-HDL cholesterol/HDL cholesterol ratio (odds ratio for each 1.070 per 1 mg/dl increment, 95% confidence interval 1.024 to 1.118, p <0.01), followed by the triglyceride/HDL cholesterol ratio (odds ratio 1.033 per 1 mg/dl increment, 95% confidence interval 1.011 to 1.056, p <0.01). Neither LDL cholesterol nor the LDL/HDL cholesterol ratio correlated significantly. Parallel analyses comparing tertile extremes and analyses in subgroups determined by gender, age, and body mass index revealed similar findings. The LDL/HDL cholesterol ratio was only significant for lean patients. In conclusion, these observations add to the published data suggesting that LDL cholesterol may not be the best target of lipid-lowering treatment strategies.
Authors:
Stanley H Hsia; Deyu Pan; Peyton Berookim; Martin L Lee
Related Documents :
8442619 - Decreased high-density lipoprotein cholesterol and increased low-density cholesterol le...
10428319 - Hormone replacement therapy and lipid-lipoprotein concentrations.
222499 - Oral contraceptive use and fasting triglyceride, plasma cholesterol and hdl cholesterol.
218069 - Hdl-cholesterol levels in the multiple risk factor intervention trial (mrfit) by the mr...
11805009 - Inaccuracy of lipid measurements with the portable cholestech l.d.x analyzer in patient...
9225239 - The relationships of testosterone, estradiol, dehydroepiandrosterone-sulfate and sex ho...
9688679 - Metabolic inhibition increases feeding and brain fos-like immunoreactivity as a functio...
9130029 - Serum leptin in relation to resting energy expenditure and fuel metabolism in obese sub...
9241589 - Strategies for preventing milk fever in dairy cattle.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2006-08-28
Journal Detail:
Title:  The American journal of cardiology     Volume:  98     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-10-09     Completed Date:  2006-11-24     Revised Date:  2007-12-03    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1047-52     Citation Subset:  AIM; IM    
Affiliation:
Division of Endocrinology, Metabolism and Molecular Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, California, USA. sthsia@cdrew.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoproteins B / blood
Atherosclerosis / blood*
Cholesterol / blood
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Cross-Sectional Studies
Demography
Female
Humans
Lipids / blood*
Male
Nutrition Surveys
Odds Ratio
Retrospective Studies
Triglycerides / blood
Grant Support
ID/Acronym/Agency:
5-U54-RR014616/RR/NCRR NIH HHS; DK54047/DK/NIDDK NIH HHS; G12RR-03026-11/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Cholesterol, HDL; 0/Cholesterol, LDL; 0/Lipids; 0/Triglycerides; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia det...
Next Document:  Comparison of body mass index versus waist circumference with the metabolic changes that increase th...